Navigation Links
Bentley Reports Positive Results with Nasulin Intranasal Insulin,Spray at the American Diabetes Association Meeting

demonstrating more rapid onset of action than Humalog. When Nasulin was administered to different nostrils in 12 healthy male subjects, no significant differences in absorption were noted, although there was a slight trend in favor of the mildly congested nostril. However, researchers concluded this difference is unlikely to be clinically important, and noted if nostrils are totally blocked, they should be cleared with gentle nose-blowing before administration.

Adverse events reported in the smoking/non-smoking and dominant nostril studies included a total of four episodes of hypoglycemia in subjects receiving the investigational drug. In addition, some volunteers experienced transient, mild nasal irritation and/or watery eyes, which resolved rapidly. These transient findings were not consistently present with each dose, and were generally resolved within 15-20 minutes.

"These trials show favorable results for Nasulin intranasal insulin spray as being equivalent in several key clinical measures when compared to the leading formulations of injectable insulin," said John Sedor, president of Bentley. "For more than two decades, the medical community has been searching for a less painful and easier method for treating diabetes than insulin injections. Nasulin presents a significant opportunity of achieving this goal for many patients and has the potential for significantly better patient compliance than a routine of insulin injections. Nasulin does not require constant refrigeration for use, and the delivery device is small enough to be carried discretely in a pocket or purse. In addition, Nasulin does not enter the lungs, avoiding possible long-term effects on lung function and holding the potential for use in diabetes patients with COPD and asthma. We are excited by the prospects for Nasulin, and Bentley is committed to finding collaboration partners to help conduct the additional clinical studies necessary to make this potentially important diabetes tre
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:6/18/2013)... 2013 , Safinamide significantly ... patients as add-on to levodopa Safinamide ... symptoms in fluctuating PD patients as add-on to ... S.p.A. ("Newron"), a research and development company focused ... partner Zambon S.p.A., a pharmaceutical company strongly committed ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... public offering of common shares (the "Offering"). Pursuant to ... at a price of $85.00 per share, for aggregate ... file a final prospectus supplement to its effective shelf ... similar filing with the securities regulatory authorities in each ...
(Date:6/18/2013)... , June 18, 2013  It has ... of Alliance Seating and Mobility, a subsidiary company ... access timely repair. This appears to be due ... reduction of field service employees.  ... great many of these clients are complex mobility ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
(Date:6/19/2013)... (PRWEB) June 19, 2013 Blueforce ... and sensor machine software, today announced it has ... its Decentralized Fusion Engine technology. The award ... the acquisition of key strategic partnerships. , ... wireless collaboration and machine-to-machine (M2M) software products that ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... 19, 2013 Walkingspree, a specialized wellness ... the launch of its new Facebook App. This is ... inspire participants to reach their program fitness goals. Consistent ... Walkingspree clients are given more tools to customize their ... , Corporate clients may choose whether or not they ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
Breaking Medicine News(10 mins):Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Stealth Grow Tent Brand’s Popularity Rises 2
... disused proteins are eliminated by a cellular shredder called ... to dispose with Ubiquitin (Ub) in order to avoid ... in the ubiquitin-proteasome system can be fatal for the ... disorders but also developmental defects are the consequences. The ...
... the first scientific review of a dozen patients who have ... gene therapy technique is safe and may be effective at ... patients, half of whom live on Long Island, are in ... to medicines when they signed on for the experimental therapy. ...
... on June 26, after spending 23 days in the slammer. ... Angeles County Sheriff's Department's Inmate Reception Center. ,The exact ... ,Although her sentence was for 45 days, authorities have said ... good behaviour. ,"There was some confusion as to whether ...
... new details about how proteins used to destroy bacteria ... ,Gunnar K. Gouras, associate professor of neurology and ... York, and colleagues provide new insights into how these ... disease and raise hopes for a vaccine against the ...
... a credible scientific method for testing and measuring ... on XanGo Juice , indicate usage of the ... to high xanthone absorption. ,XanGo, LLC, ... leading scientific exploration of the whole mangosteen fruit ...
... is making all possible arrangements to look good on her yet ... thing that the socialite will do after being released on June ... complained to the press while in jail that she's not permitted ... going dry. ,So, the heiress has booked a facial ...
Cached Medicine News:Health News:Protein Targets for Carcinogenesis 2Health News:Gene Therapy for Parkinsons Disease 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3
Blunt Weitlaner Retractor....
Weitlaner Beckmann retractor, sharp prongs, SS....
Baby Weitlaner retractor, blunt, 4"....
Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....
Medicine Products: